Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and Hemorrhagic Fever, American

pyrazines has been researched along with Hemorrhagic Fever, American in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Abe, H; Afowowe, TO; Urata, S; Yasuda, J; Zadeh, VR1
Bailey, KW; Gantla, VR; Gowen, BB; Henkel, G; Hickerson, BT; McCormack, K; Naik, S; Wandersee, L; Westover, JB1
Bailey, KW; Furuta, Y; Gowen, BB; Komeno, T; Sefing, EJ; Van Wettere, AJ; Wandersee, L; Westover, JB1
Brasel, T; Freiberg, AN; Furuta, Y; Gowen, BB; Hill, TE; Juelich, TL; Pietzsch, C; Sefing, EJ; Smith, JK; Tigabu, B; Yun, T; Zhang, L1
Bailey, KW; Bray, M; Dagley, A; Downs, B; Furuta, Y; Gowen, BB; Jung, KH; Sefing, EJ; Smee, DF; Van Wettere, AJ; Wandersee, L; Westover, JB1
Furuta, Y; Gowen, BB; Hall, JO; Mendenhall, M; Russell, A; Skirpstunas, R; Smee, DF1

Other Studies

6 other study(ies) available for pyrazines and Hemorrhagic Fever, American

ArticleYear
Potential and action mechanism of favipiravir as an antiviral against Junin virus.
    PLoS pathogens, 2022, Volume: 18, Issue:7

    Topics: Amides; Antiviral Agents; Arenavirus; Hemorrhagic Fever, American; Humans; Junin virus; Pyrazines; RNA-Dependent RNA Polymerase; Virus Replication

2022
Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir.
    Antiviral research, 2022, Volume: 208

    Topics: Amides; Animals; Anti-Retroviral Agents; Arenaviridae; Guinea Pigs; Hemorrhagic Fever, American; Hemorrhagic Fevers, Viral; Junin virus; Mice; Pyrazines

2022
Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.
    Antiviral research, 2017, Volume: 145

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Hemorrhagic Fever, American; Junin virus; Pyrazines; Survival Analysis; Viral Load

2017
Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:12

    Topics: Administration, Oral; Amides; Animals; Antiviral Agents; Disease Models, Animal; Guinea Pigs; Hemorrhagic Fever, American; Injections, Intraperitoneal; Junin virus; Male; Plasma; Pyrazines; Survival Analysis; Viremia

2013
Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Antiviral research, 2016, Volume: 126

    Topics: Amides; Animals; Antiviral Agents; Arenavirus; Chlorocebus aethiops; Cricetinae; Dengue Virus; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, American; Hemorrhagic Fever, Ebola; Hemorrhagic Fevers, Viral; Junin virus; Male; Mesocricetus; Mice; Orthohantavirus; Pyrazines; Ribavirin; RNA Viruses; Vero Cells

2016
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
    PLoS neglected tropical diseases, 2011, Volume: 5, Issue:10

    Topics: Amides; Animals; Antiviral Agents; Arenavirus; Disease Models, Animal; Guinea Pigs; Hemorrhagic Fever, American; Humans; Lethal Dose 50; Male; Molecular Sequence Data; Pyrazines; RNA, Viral; Sequence Analysis, DNA; Survival Analysis; Treatment Outcome

2011